IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although there are scant published data discussing the safety in pregnant women with chronic HBV infection, IFN has been recommended widely in MS, ET, chronic myeloid leukemia, multiple myeloma, and others (46–48).